Merk reported $3.12B in Operating Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2510M 965M
Abbvie ABBV:US $ 3753M 498M
Amgen AMGN:US $ 2008M 445M
AstraZeneca AZN:LN 1.49B 316M
Astrazeneca AZN:US 1.49B 316M
Biogen BIIB:US $ -330.6M 1417M
Bristol Myers Squibb BMY:US $ -11831M 13212M
Catalent CTLT:US $ 126.6M 45.1M
Eli Lilly And LLY:US $ 1992.1M 713.8M
Gilead Sciences GILD:US $ 2651M 650M
GlaxoSmithKline GSK:LN 1.06B 797M
Glaxosmithkline GSK:US $ 1061M 797M
JAZZ PHA JAZZ:US $ 173.41M 22.19M
Johnson & Johnson JNJ:US $ 1647M 2754M
Medtronic MDT:US $ 1277M 655M
Novartis NOVN:VX 2.64B 292M
Novartis NVS:US $ 2644M 232M
Perrigo Ordinary Shares PRGO:US $ -115.5M 232.9M
Pfizer PFE:US $ 524M 1761M
Phibro Animal Health PAHC:US $ 19.89M 4.2M
Prestige Brands PBH:US $ 73.44M 0.54M
Regeneron Pharmaceuticals REGN:US $ 1167M 113.9M
Zoetis ZTS:US $ 420M 177M